{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1482","meta":{"versionId":"12","lastUpdated":"2021-03-04T01:00:30.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-04"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1482","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1482"}],"version":"20210304","name":"AntiInfectivesOther","title":"Anti Infectives, other","status":"active","experimental":false,"date":"2021-03-04T01:00:30-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for nitrofurantoin medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, prescribable nitrofurantoin and nitrofurantoin in combination with other medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and excludes concepts that represent components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1648755","display":"nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule"},{"code":"1648759","display":"nitrofurantoin, macrocrystals 100 MG Oral Capsule"},{"code":"311989","display":"nitrofurantoin 5 MG/ML Oral Suspension"},{"code":"311994","display":"nitrofurantoin, macrocrystals 25 MG Oral Capsule"},{"code":"311995","display":"nitrofurantoin, macrocrystals 50 MG Oral Capsule"}]}]},"expansion":{"identifier":"urn:uuid:9801bf9b-289e-4bb6-bdda-a69dd4995d14","timestamp":"2023-12-11T02:33:28-05:00","total":5,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1648755","display":"nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1648759","display":"nitrofurantoin, macrocrystals 100 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"311989","display":"nitrofurantoin 5 MG/ML Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"311994","display":"nitrofurantoin, macrocrystals 25 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"311995","display":"nitrofurantoin, macrocrystals 50 MG Oral Capsule"}]}}